A Canadian fish oil supplement supplier, a business that hopes to enter the medical marijuana industry, is warning of the risks posed by the “rapidly-evolving” cannabis industry and uncertainty over Health Canada’s license approval process.

Health, safety and environmental regulations “are subject to change and development,” Neptune Technologies & Bioressources Inc. said in its management discussion and analysis of its financial results, released Tuesday. Quebec-based Neptune, a vendor of fish oil, is applying for a licence with Health Canada to produce cannabis oil.

Waterloo Medical Cannabis Clinic launches to meet the region’s growing demand for the product.

The inspiration for the newest cannabis clinic in the Waterloo Region came from Dave Schenk’s personal experience with the medicinal properties of the drug, slated to be legal for recreational use in July.

“I was relying on ibuprofen to get through the days from arthritis pain,” explained Schenk, a former investment banker who’s now manager of the Waterloo Medical Cannabis Clinic, part of The Clinic Network, which operates 10 medical marijuana centres across the country.

BLOCKSTRAIN TECHNOLOGY CORP. (the "Company" or "BLOCKStrain") (TSXV: DNAX) is pleased to announce that cannabis pioneer Derek Pedro has agreed to join the Company's Advisory Board.

Mr. Pedro was a co-founder and Master Grower at Maricann Group Inc., an early Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and is currently the Design, Cultivation and Production Partner at WeedMD Inc., where he designed and supervised construction of that company's production facility in Ontario.

There's little evidence that legalized marijuana poses a threat to public health and safety, and there may be benefits, says a new study from Canadian doctors and researchers.

The report, submitted to the Senate this week, outlines the positive and negative impacts legalization has had in other jurisdictions.

"It hasn't been a public health disaster or crisis yet, but there are some key areas that we need to watch," said Rebecca Haines-Saah, a public health specialist at the University of Calgary and one of the report's authors.

The federal government has promised to legalize recreational marijuana later this year under Bill C-45, which is expected to go to a final vote in the upper house Thursday.

CEO Perry Davidson:  We're a hardware company, a medical devices company, for administering medical cannabis.

The capital market has been swooning recently over listed cannabis companies, especially over the as yet unfulfilled promise of marketing the product overseas. Meanwhile, while approval for exporting cannabis is being delayed, quite a few less prominent private companies are starting to fulfill their promises in the Israeli market.

Medical Marijuana Producer Assessing Their Contact Center Operations in Advance of the Introduction of Recreational Cannabis

Taylor Reach Group is conducting an in-depth analysis of people, process, technologies and the ‘thousand moving parts’ within one of Canada’s Medical Marijuana Producer’s Contact Center to support the increasing contact volumes and establish a prescriptive approach for optimizing operations.

The Taylor Reach Strategic Assessment will enable scalability through the analysis of people, process and technologies to establish a prescriptive approach for optimizing operations

Cubic Health Inc. has introduced a risk management program aimed at helping plan sponsors with the many considerations for covering medical marijuana in their benefits plans.

The program uses claims data from the past two or three years to provide evidence-based education that’s tailored to a plan sponsor’s industry and workforce. It also includes a tailored risk assessment for each benefits plan that quantifies and anticipates its exposure to legitimate claims for medical cannabis over the next two years, according to Mike Sullivan, chief executive officer at Cubic Health.

Look out dot.com era! Here comes the pot.com era!

With a medical and recreational marijuana industry about to fly, there’s a whole lot of buzz going on. Globally-competitive, lucrative sectors and commercial opportunities are predicted to grow like a weed!

Cannabusiness is set to be smoking – forecasts of the medical marijuana market predict US$31 billion in annual sales by 2021. A Deloitte study suggests recreational marijuana sales alone in Canada could be as high as $8.7 billion per year.

Colorado allergist sees worst symptoms reported by industry workers handling plants.

Soon-to-be-legal cannabis may have some Canadians sniffling and sneezing.

As more people try cannabis for the first time, or the first time in years, a rare but real allergy may appear with symptoms such as sniffles or hives, similar to those that come from a seasonal allergy to pollen.

"Suddenly nose running, eyes itchy, sneezing — that's probably a minor reaction to cannabis and marijuana, and you probably want to avoid that kind of setting in the future," said Dr. Eddy Lang, who oversees emergency rooms in four Calgary-area adult hospitals.

The company is putting a pharmaceutical spin on the growing cannabis market.

The cannabis market is full of potential and creativity, with companies introducing new and innovative products every day. Dispensaries have gone way beyond smokable marijuana, offering customers everything from cannabis-infused edibles like beer and chocolate to personal care products like lotion and eye creams.

But the cannabis market isn’t all fun and games. Canntab Therapeutics Ltd. (CSE:PILL) is looking to fill a need in the pharmaceutical space.